Skip to main content

Peer Review reports

From: ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway

Original Submission
6 Nov 2019 Submitted Original manuscript
29 Nov 2019 Author responded Author comments - Han Chen
Resubmission - Version 2
29 Nov 2019 Submitted Manuscript version 2
17 Dec 2019 Reviewed Reviewer Report - Soona Shin
19 Dec 2019 Reviewed Reviewer Report - Asha Balakrishnan
8 Jul 2020 Author responded Author comments - Han Chen
Resubmission - Version 3
8 Jul 2020 Submitted Manuscript version 3
16 Jul 2020 Author responded Author comments - Han Chen
Resubmission - Version 4
16 Jul 2020 Submitted Manuscript version 4
20 Jul 2020 Author responded Author comments - Han Chen
Resubmission - Version 5
20 Jul 2020 Submitted Manuscript version 5
22 Jul 2020 Author responded Author comments - Han Chen
Resubmission - Version 6
22 Jul 2020 Submitted Manuscript version 6
29 Jul 2020 Author responded Author comments - Han Chen
Resubmission - Version 7
29 Jul 2020 Submitted Manuscript version 7
10 Aug 2020 Author responded Author comments - Han Chen
Resubmission - Version 8
10 Aug 2020 Submitted Manuscript version 8
23 Aug 2020 Author responded Author comments - Han Chen
Resubmission - Version 9
23 Aug 2020 Submitted Manuscript version 9
Publishing
31 Aug 2020 Editorially accepted
5 Sep 2020 Article published 10.1186/s12885-020-07367-2

You can find further information about peer review here.

Back to article page